Half Year 2021 Oxford BioMedica PLC Earnings Call Transcript
Good afternoon, ladies and gentlemen. Welcome to Oxford Biomedica's Half Year Results Analyst Meeting and Conference Call for the 6 Months Ending 30 June 2021.
We're delighted to see many of you in person today to talk through what hopefully you will agree is a strong set of results. (Operator Instructions) And the presentation is being recorded. (Operator Instructions)
To discuss in more detail, I would like to introduce the presenters on the call today. We have our CEO, John Dawson; our CFO, Stuart Paynter; and our Chief Scientific Officer, Kyri Mitrophanous.
With that, I would like to hand over to John.
Thank you very much. And I'll first say, it's great to see you all face to face. It's been a while since we've been able to do this. It has a lot more impact when we do it sitting with you. Of course, the guys on the phone, it's great to have them there as well. It's a pleasure to have you all here to talk about our results
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

